2005 Volume 25 Issue 1 Pages 18-21
Carboplatin (CP) is commonly used for the treatment of ovarian carcinoma. Anaphylactic reaction to CP is rare, but it could be life-threatening. The risk of hypersensitivity reactions to CP increases during the course of frequent treatments for relapsed ovarian carcinoma. Although several investigators have reported hypersensitivity reactions to intravenously administered CP, few case reports have been presented regarding hypersensitivity reactions to intraperitonealy administered CP. We report here a case of an intraoperative anaphylactic reaction to intraperitonealy administered CP in a 57-year-old woman who had received ten courses of CP treatment.
